Status:
UNKNOWN
Metacognitive Therapy and Work Interventions for Patients on Sick Leave Due to Common Mental Disorders
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
Diakonhjemmet Hospital
Conditions:
Anxiety
Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Common mental health disorders such as anxiety and depression are leading causes of sickness absence and disability in Norway. Despite tremendous costs for individual and society, effective treatment ...
Detailed Description
Common mental health disorders (CMD) such as anxiety and depression are leading contributors to the global burden of disease , generating substantial costs for societies in reduced productivity and in...
Eligibility Criteria
Inclusion
- on sick leave either partial or full, due to
- clinically relevant level of anxiety and depression, and
- eligible for work-related sick leave pay outs
- given consent
Exclusion
- Serious mental illness (such as bipolar disorder or schizophrenia)
- Substance abuse
- Cluster A and B personality disorder
Key Trial Info
Start Date :
October 31 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2023
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT03301922
Start Date
October 31 2017
End Date
April 1 2023
Last Update
September 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Poliklinikken Raskere Tilbake, Diakonhjemmet Sykehus
Oslo, Norway